Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Hair loss linked to higher heart disease risk in both men and women.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Hair grays due to oxidative stress and fewer functioning melanocytes.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.